Randomized Phase II Trial of Dendritic Cell/Myeloma Fusion Vaccine with Lenalidomide Maintenance after Upfront Autologous Hematopoietic Cell Transplantation for Multiple Myeloma: BMT CTN 1401

Vaccination with dendritic cell (DC)/multiple myeloma (MM) fusions has been shown to induce the expansion of circulating multiple myeloma-reactive lymphocytes and consolidation of clinical response following autologous hematopoietic cell transplant (auto-HCT). In this randomized phase II trial (NCT0...

Celý popis

Podrobná bibliografia

Vydané v:	Clinical cancer research Ročník 29; číslo 23; s. 4784
Hlavní autori:	Chung, David J, Shah, Nina, Wu, Juan, Logan, Brent, Bisharat, Lina, Callander, Natalie, Cheloni, Giulia, Anderson, Kenneth, Chodon, Thinle, Dhakal, Binod, Devine, Steve, Somaiya Dutt, Poorvi, Efebera, Yvonne, Geller, Nancy, Ghiasuddin, Haider, Hematti, Peiman, Holmberg, Leona, Howard, Alan, Johnson, Bryon, Karagkouni, Dimitra, Lazarus, Hillard M, Malek, Ehsan, McCarthy, Philip, McKenna, David, Mendizabal, Adam, Nooka, Ajay, Munshi, Nikhil, O'Donnell, Lynn, Rapoport, Aaron P, Reese, Jane, Rosenblatt, Jacalyn, Soiffer, Robert, Stroopinsky, Dina, Uhl, Lynne, Vlachos, Ioannis S, Waller, Edmund K, Young, James W, Pasquini, Marcelo C, Avigan, David
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States 01.12.2023
Predmet:	Antineoplastic Combined Chemotherapy Protocols - adverse effects Dendritic Cells Dexamethasone - therapeutic use Granulocyte-Macrophage Colony-Stimulating Factor - genetics Hematopoietic Stem Cell Transplantation Humans Lenalidomide - therapeutic use Multiple Myeloma - drug therapy Transplantation, Autologous
ISSN:	1557-3265, 1557-3265
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!